Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

12 results
Display

Could Antibiotic Resistance Rate of Helicobacter pylori be Different according to Gastroduodenal Diseases?

Shin WG

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages

Cheung DY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Helicobacter pylori Eradication Therapy in Korea

Kim SY, Jung SW

Helicobacter pylori (H. pylori) is known to be associated with many gastrointestinal diseases including peptic ulcer. In Korea, eradication of H. pylori is recommended for peptic ulcer disease, low grade...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Resolution of Menetrier's Disease after Helicobacter pylori Eradication

Jung JH, Hong SJ, Lee MS

  • KMID: 782730
  • Korean J Gastroenterol.
  • 2006 Jul;48(1):1-3.
No abstract availble.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Outcome of Immunosuppressive Therapy with Helicobacter pylori Eradication Therapy in Patients with Chronic Idiopathic Thrombocytopenic Purpura

Song MK, Chung JS, Shin HJ, Choi YJ, Cho GJ

We initiated this study to investigate whether combining Helicobacter pylori eradication with immunosuppressive therapy provides an additional benefit to patients with idiopathic thrombocytopenic purpura (ITP) that has relapsed or has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial

Choi KH, Chung WC, Lee KM, Paik CN, Kim EJ, Kang BK, Oak JH, Jung SH

The aim of this study was to evaluate the efficacy of levofloxacin and rifaximin based quadruple regimen as first-line treatment for Helicobacter pylori infection. A prospectively randomized, double-blinded, parallel group,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Helicobacter pylori Eradication Therapy Is Effective as the Initial Treatment for Patients with H. pylori-Negative and Disseminated Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Gong EJ, Ahn JY, Jung HY, Park H, Ko YB, Na HK, Jung KW, Kim DH, Lee JH, Choi KD, Song HJ, Lee GH, Kim JH

BACKGROUND/AIMS: We investigated the effectiveness of Helicobacter pylori eradication therapy for gastric mucosa-associated lymphoid tissue (MALT) lymphoma regardless of the H. pylori infection status or disease stage. METHODS: From November 1995...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Helicobacter pylori Eradication Rate in Patients with Non-ulcer Dyspepsia and Peptic Ulcer Diseases according to Proton Pump Inhibitors

Hong EJ, Park DI, Oh SJ, Song MJ, Choi WH, Hong CH, Park JH, Kim HJ, Cho YK, Shon CI, Jeon WK, Kim BI

  • KMID: 783038
  • Korean J Gastroenterol.
  • 2008 Aug;52(2):80-85.
BACKGROUND/AIMS: Conflicting results have been reported whether patients with non-ulcer dyspepsia (NUD) respond differently to Helicobacter pylori (H. pylori) eradication treatment compared with patients with peptic ulcer diseases (PUD). The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea

Chung KH, Lee DH, Jin E, Cho Y, Seo JY, Kim N, Jeong SH, Kim JW, Hwang JH, Shin CM

BACKGROUND/AIMS: Retreatment after initial treatment failure for Helicobacter pylori is very challenging. The purpose of this study was to evaluate the efficacies of moxifloxacin-containing triple and bismuth-containing quadruple therapy. METHODS: A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effectiveness of Triple Therapy and Quadruple Therapy for Helicobacter pylori Eradication

Jang HJ, Choi MH, Kim YS, Seo YA, Baik KH, Baik IH, Eun CS, Kim JB, Kae SH, Kim DJ, Lee MS, Kim HY, Lee J

  • KMID: 772859
  • Korean J Gastroenterol.
  • 2005 Nov;46(5):368-372.
BACKGROUND/AIMS: Quadruple therapy can be considered as a first-line therapy in areas where the resistance rate to clarithromycin is high. Comparison study of triple therapy and quadruple therapy for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cronkhite-Canada Syndrome Showing Resolution with Helicobactor pylori Eradication and Omeprazole

Kim MS, Jung HK, Jung HS, Choi JY, Na YJ, Pyun GW, Ryu JH, Moon IH, Jo MS

  • KMID: 1079905
  • Korean J Gastroenterol.
  • 2006 Jan;47(1):59-64.
We describe a 58-year-old woman who was incidentally found to have gastric and colonic polyposis, hypoalbuminemia, cutaneous hyperpigmentation and onychodystrophy (Cronkhite-Canada syndrome). Histology of polyps from the stomach showed features...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Helicobacter pylori Eradication for Stage IE1 Gastric Mucosa-associated Lymphoid Tissue Lymphoma: Predictive Factors of Complete Remission

Kim SJ, Yang S, Min BH, Lee JH, Rhee PL, Rhee JC, Kim JJ

BACKGROUND/AIMS: Eradication of Helicobacter pylori (H. pylori) is accepted as initial treatment of stage IE1 gastric mucosa associated lymphoid tissue (MALT) lymphoma. However, 10-20% of gastric low grade MALT lymphomas...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr